Dear Friends and Colleagues,
We are pleased to announce the 1st Therapeutic Antibody Workshop: along the path from Target Genes to Patients which will take place on 8 November 2019 at Castel Romano, Rome.
Educational Goals and Didactics
The monoclonal antibody (mAb) market has changed rapidly in the past 5 years: it has doubled in size, becoming dominated by fully human molecules, launched bispecific molecules, and faced competition from biosimilars. Therefore, Antibody generation and engineering is a growing area with lots of exciting developments and many clinical achievements.
At the 1st Therapeutic Antibody Workshop: along the path from Target Genes to Patients, you will attend a full day of intensive instructional presentations that will take you from the desired target identification concepts through real world applications. This workshop will be taught by scientists with long experience, who will focus on content applicable to current research goals, available antibody platform technologies, process development, GMP production, regulatory preclinical studies and clinical applications. The presentations will include real-life case studies, problems encountered and solutions applied, along with extensive coverage of theory and background. At the same time, examples of how different expertise may be combined will be provided. Each presentation will offer a mix of formal lecture and interactive discussions and activities to maximize the learning experience.
We are sure that you will enjoy very much this exciting Workshop.
Organizing committee: Giuseppe Roscilli, Emanuele Marra, Cinzia Roffi, Monica Fraternali